Michaela A E Arndt

Author PubWeight™ 8.00^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.	J Virol	2010	0.91
2	Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment.	Protein Eng	2003	0.90
3	Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.	Proc Natl Acad Sci U S A	2013	0.85
4	Targeted therapeutic RNases (ImmunoRNases).	Expert Opin Biol Ther	2009	0.80
5	Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme.	Br J Haematol	2005	0.79
6	High-level production of a humanized immunoRNase fusion protein from stably transfected myeloma cells.	Methods Mol Biol	2009	0.78
7	Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.	Biochem Biophys Res Commun	2005	0.77
8	Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.	MAbs	2014	0.76
9	Antibody-targeted RNase fusion proteins (immunoRNases) for cancer therapy.	Curr Pharm Biotechnol	2008	0.75
10	Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.	Int J Cancer	2014	0.75